Status:
COMPLETED
Assessment of Bleeding Symptoms in Normal Individuals Using a Comprehensive History Phenotyping Instrument
Lead Sponsor:
Rockefeller University
Collaborating Sponsors:
Weill Medical College of Cornell University
Conditions:
Bleeding Disorder
Eligibility:
All Genders
18+ years
Brief Summary
A wide variety of individuals are at risk for bleeding, but even though bleeding symptoms are common it is difficult to compare different people's symptoms. Recent research has found that carefully de...
Eligibility Criteria
Inclusion
- At least 18 years of age.
- Self-assessed as being generally healthy.
- Self-assessed as being able to accurately read and answer questions in English about their past medical histories.
Exclusion
- A diagnosis of any disorder of hemostasis.
- A diagnosis of any condition associated with an increased risk of bleeding, namely, any current or previous diagnosis of liver or kidney disease, and malignancy requiring treatment within the past year.
- Use of heparin, low-molecular weight heparins, warfarin, clopidogrel, or other medications with known anticoagulant or anti-platelet properties in the past 30 days.
- History, physical, or known laboratory findings suggestive of any other medical or psychological condition that would impair the participant's ability to accurately respond to questions about bleeding symptoms.
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
412 Patients enrolled
Trial Details
Trial ID
NCT00772434
Start Date
September 1 2008
End Date
May 1 2011
Last Update
November 18 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rockefeller University Hospital
New York, New York, United States, 10065